Growth hormone and body composition in children younger than 2 years with Prader-Willi syndrome

Journal of Pediatrics

Volumn 144, Issue 6, 2004, Pages 753-758

  Eiholzer, Urs ^a   L'Allemand, Dagmar ^b   Schlumpf, Michael ^b   Rousson, Valentin ^b   Gasser, Theo ^b   Fusch, Christoph ^b  

^a Foundation Growth Puberty Adolescence Zurich   (Switzerland)

^b NONE

Author keywords

FMAge; Coenzyme Q10; CoQ10; Fat mass; FM; GH; Growth hormone; Lean mass; Lean mass adjusted for height; LM; LM Ht; Percentage of fat adjusted for age; Prader Willi syndrome; PWS; SDS; Standard deviation score; WfH

Indexed keywords

HUMAN GROWTH HORMONE; RECOMBINANT GROWTH HORMONE; SANOMIT; UBIDECARENONE;

ARTICLE; BODY COMPOSITION; BODY FAT; BODY HEIGHT; BODY WEIGHT; CALCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; HORMONAL THERAPY; HUMAN; INFANT; LEAN BODY WEIGHT; MALE; OBESITY; PRADER WILLI SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL; SCORING SYSTEM;

BODY COMPOSITION; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INFANT; MALE; OBESITY; PRADER-WILLI SYNDROME; RECOMBINANT PROTEINS; STATISTICS, NONPARAMETRIC; UBIQUINONE;

EID: 3042832989     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2004.03.005     Document Type: Article

References (38)

1. Gunay-Aygun M., Schwartz S., Heeger S., O'Riordan M.A., Cassidy S.B. The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria. Pediatrics. 108:2001;E92
2. Eiholzer U. Prader-Willi syndrome: Effects of human growth hormone treatment. 2001;Karger, Basel
3. Eiholzer U., Blum W.F., Molinari L. Body fat determined by skinfold measurements is elevated despite underweight in infants with Prader-Labhart-Willi syndrome. J Pediatr. 134:1999;222-225
4. Bekx M.T., Carrel A.L., Shriver T.C., Li Z., Allen D.B. Decreased energy expenditure is caused by abnormal body composition in infants with Prader-Willi Syndrome. J Pediatr. 143:2003;372-376
5. Whittington J., Holland A., Webb T., Butler J., Clarke D., Boer H. Relationship between clinical and genetic diagnosis of Prader-Willi syndrome. J Med Genet. 39:2002;926-932
6. Gillessen-Kaesbach G., Gross S., Kaya-Westerloh S., Passarge E., Horsthemke B. DNA methylation based testing of 450 patients suspected of having Prader-Willi syndrome. J Med Genet. 32:1995;88-92
7. Buiting K., Gross S., Lich C., Gillessen-Kaesbach G., El Maarri O., Horsthemke B. Epimutations in Prader-Willi and Angelman syndromes: a molecular study of 136 patients with an imprinting defect. Am J Hum Genet. 72:2003;571-577
8. Eiholzer U., l'Allemand D. Growth hormone normalises height, prediction of final height and hand length in children with Prader-Willi syndrome after four years of therapy. Horm Res. 53:2000;185-192
9. Butler M.G., Dasouki M., Bittel D., Hunter S., Naini A., DiMauro S. Coenzyme Q10 levels in Prader-Willi syndrome: comparison with obese and non-obese subjects. Am J Med Genet. 119A:2003;168-171
10. Prader A., Largo R., Molinari L., Issler C. Physical growth of Swiss children form birth to 20 years of age. Helv Paediatr Acta. 43:(Suppl 52):1989;1-125
11. Fusch C., Scharrer B., Hungerland E., Moeller H. Body water, lean body and fat mass of healthy children as measured by deuterium oxide dilution. Isotopenpraxis Environ Health Studies. 29:1993;125-131
12. Wabitsch M., Braun U., Heinze E., Muche R., Mayer H., Teller W., et al. Body composition in 5- to 18-y-old obese children and adolescents before and after weight reduction as assessed by deuterium dilution and bioelectrical impedance analysis. Am J Clin Nutr. 64:1996;1-6
13. Gasser T. Development of fat tissue and body mass index from infancy to adulthood. Pediatr Nephrol. 10:1996;340-342
14. Butte N., Heinz C., Hopkinson J., Wong W., Shypailo R., Ellis K. Fat mass in infants and toddlers: comparability of total body water, total body potassium, total body electrical conductivity, and dual- energy X-ray absorptiometry. J Pediatr Gastroenterol Nutr. 29:1999;184-189
15. Eiholzer U., l'Allemand D., van der Sluis I., Steinert H., Ellis K. Body composition abnormalities in children with Prader-Willi syndrome and long-term effects of growth hormone therapy. Horm Res. 53:2000;200-206
16. Brambilla P., Bosio L., Manzoni P., Pietrobelli A., Beccaria L., Chiumello G. Peculiar body composition in patients with Prader-Labhart-Willi syndrome. Am J Clin Nutr. 65:1997;1369-1374
17. Nordmann Y., Eiholzer U., l'Allemand D., Mirjanic S., Markwalder C. Sudden death of an infant with Pader-Willi syndrome: not a unique case? Biol Neonate. 82:2002;139-141
18. Nixon G.M., Brouillette R.T. Sleep and breathing in Prader-Willi syndrome. Pediatr Pulmonol. 34:2002;209-217
19. Eiholzer U. Mortality in children with Prader-Willi Syndrome: a contribution to the debate about the safety of growth hormone treatment in children with PWS. Horm Res, 2004; in press.
20. Eiholzer U. A Comprehensive Approach to Limiting Weight Gain and to Normalizing Body Composition in Prader-Willi Syndrome. Eiholzer U., l'Allemand D., Zipf W. Prader-Willi Syndrome as a model for obesity. 2003;211-221 Karger, Basel
21. Carrel A.L., Allen D.B. Prader-Willi syndrome: how does growth hormone affect body composition and physical function? J Pediatr Endocrinol Metab. 14:(Suppl 6):2001;1445-1451
22. Frisch H. Growth hormone and body composition in athletes. J Endocrinol Invest. 22:1999;106-109
23. van Mil E.G., Westerterp K.R., Gerver W.J., Marken Lichtenbelt W.D., Kester A.D., Saris W.H. Body composition in Prader-Willi syndrome compared with nonsyndromal obesity: relationship to physical activity and growth hormone function. J Pediatr. 139:2001;708-714
24. Eiholzer U., Nordmann Y., l'Allemand D., Schlumpf M., Schmid S., Kromeyer-Hauschild K. Improving body composition and physical activity in Prader-Willi Syndrome. J Pediatr. 142:2003;73-78
25. Carrel A., Myers S., Whitman B., Allen D. Growth hormone improves body composition, fat utilization, physical strength and agility in Prader-Willi syndrome: a controlled study. J Pediatr. 134:1999;215-221
26. Carrel A.L., Myers S.E., Whitman B.Y., Allen D.B. Benefits of long-term GH therapy in Prader-Willi syndrome: a 4-year study. J Clin Endocrinol Metab. 87:2002;1581-1585
27. Eiholzer U., Gisin R., Weinmann C., Kriemler S., Steinert H., Torresani T., et al. Treatment with human growth hormone in patients with Prader-Labhart-Willi syndrome reduces body fat and increases muscle mass and physical performance. Eur J Pediatr. 157:1998;368-377
28. Hoos MB, Westerterp KR, Kuipers H, Schuwirth L, Gerver WJ. Physical activity in children receiving growth hormone therapy as measured by tri-axial accelerometry. 2003. p. 61-9.
29. Schoeller D., Levitsky L., Bandini L., Dietz W., Walczak A. Energy expenditure and body composition in Prader-Willi syndrome. Metabolism. 37:1988;115-120
30. van Mil E.A., Westerterp K.R., Gerver W.J., Curfs L.M., Schrander-Stumpel C.T., Kester A.D., et al. Energy expenditure at rest and during sleep in children with Prader-Willi syndrome is explained by body composition. Am J Clin Nutr. 71:2000;752-756
31. van Mil E.G., Westerterp K.R., Kester A.D., Curfs L.M., Gerver W.J., Schrander-Stumpel C.T., et al. Activity related energy expenditure in children and adolescents with Prader-Willi syndrome. [In Process Citation] Int J Obes Relat Metab Disord. 24:2000;429-434
32. Lindgren A.C., Barkeling B., Hagg A., Ritzen E.M., Marcus C., Rossner S. Eating behavior in Prader-Willi syndrome, normal weight, and obese control groups. J Pediatr. 137:2000;50-55
33. Holland A.J., Treasure J., Coskeran P., Dallow J., Milton N., Hillhouse E. Measurement of excessive appetite and metabolic changes in Prader-Willi syndrome. Int J Obes Relat Metab Disord. 17:1993;527-532
34. Holland A.J., Treasure J., Coskeran P., Dallow J. Characteristics of the eating disorder in Prader-Willi syndrome: implications for treatment. J Intellect Disabil Res. 39:1995;373-381
35. Lindgren A.C., Hagenas L., Muller J., Blichfeldt S., Rosenborg M., Brismar T., et al. Growth hormone treatment of children with Prader-Willi syndrome affects linear growth and body composition favourably. Acta Paediatr. 87:1998;28-31
36. Lindgren A.C., Ritzen E.M. Five years of growth hormone treatment in children with Prader-Willi syndrome: Swedish National Growth Hormone Advisory Group. Acta Paediatr Suppl. 88:1999;109-111
37. van Mil G.A.H., Westerterp K.R., Gerver W.J., Curfs L.M., Schrander-Stumpel C.T.R., Saris W.H.M. Fat-free mass as a function of fat mass in children with Prader-Willi syndrome. Int J Obes Relat Metab Disord. 23:(Suppl 3):1999;45
38. Forbes G.B. Body Composition in Obesity. Forbes G.B. Human Body Composition. 1987;212-217 Springer, New York